Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes.

de Swart, Louise

Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes. [electronic resource] - Haematologica 01 2018 - 69-79 p. digital

Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

1592-8721

10.3324/haematol.2017.171884 doi


Adult
Aged
Aged, 80 and over
Biomarkers
Blood Transfusion--methods
Erythropoietin--therapeutic use
Female
Humans
Iron--metabolism
Iron Overload--etiology
Male
Middle Aged
Myelodysplastic Syndromes--blood
Prognosis
Proportional Hazards Models